"Patents as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about exclusive legal rights or privileges applied to inventions, plants, etc.
| Descriptor ID |
D010330
|
| MeSH Number(s) |
I01.880.604.583.458.650 N03.706.535.518.650
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Patents as Topic".
Below are MeSH descriptors whose meaning is more specific than "Patents as Topic".
This graph shows the total number of publications written about "Patents as Topic" by people in this website by year, and whether "Patents as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Patents as Topic" by people in Profiles.
-
Gene Patents in Canada: Is There a New Legal Landscape? Mol Diagn Ther. 2018 04; 22(2):149-155.
-
Myriad take two: Can genomic databases remain secret? Science. 2017 05 12; 356(6338):586-587.
-
Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors: a patent and scientific literature review (2002-2016). Expert Opin Ther Pat. 2017 Jun; 27(6):677-690.
-
Persistent confusion and controversy surrounding gene patents. Nat Biotechnol. 2016 Feb; 34(2):145-7.
-
Novel N-pyrimidin-4-yl-3-amino-pyrrolo [3, 4-C] pyrazole derivatives as PKC kinase inhibitors: a patent evaluation of US2015099743 (A1). Expert Opin Ther Pat. 2016; 26(4):523-8.
-
Do recent US Supreme Court rulings on patenting of genes and genetic diagnostics affect the practice of genetic screening and diagnosis in prenatal and reproductive care? Prenat Diagn. 2014 Oct; 34(10):921-6.
-
A new class of UDP-3-O-(R-3-hydroxymyristol)-N-acetylglucosamine deacetylase (LpxC) inhibitors for the treatment of Gram-negative infections: PCT application WO 2008027466. Expert Opin Ther Pat. 2009 Jun; 19(6):893-9.
-
Update on aurora kinase inhibitors in gynecologic malignancies. Recent Pat Anticancer Drug Discov. 2008 Nov; 3(3):162-77.
-
Omacetaxine mepesuccinate--a semisynthetic formulation of the natural antitumoral alkaloid homoharringtonine, for chronic myelocytic leukemia and other myeloid malignancies. IDrugs. 2008 May; 11(5):356-72.
-
The androgen receptor as putative therapeutic target in hormone-refractory prostate cancer. Recent Pat Anticancer Drug Discov. 2007 Nov; 2(3):203-11.